Each year, an estimated 15 million people around the globe experience stroke, according to the World Health Organization, ...

The standard dosing regimen was 700 mg of donanemab for the first three infusions, then 1,400 mg for each infusion after that ...

Report Ocean has published a new report on the Edema Clinical Trials Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

Approved by the FDA in July to treat adults with early symptomatic Alzheimer’s disease, Eli Lilly’s Kisunla reduced the brain ...

Eli Lilly & Co. said that a small change in dosing its Alzheimer’s drug Kisunla cut patients’ rate of brain-swelling side ...

Matt Giegengack, MD, explains how injectable corneal endothelial cell therapy can enhance visual acuity and alleviate glare, ...

As OA progresses, it can lead to reduced mobility and bone spurs, further limiting movement. Arthritis includes over 100 ...

Intellia Therapeutics fell 20.5% the day after it reported Phase 2 test results for a promising treatment. Explore more ...

The study is the first retina trial for historically underrepresented populations. “Vabysmo has been shown to be an effective ...

Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum ...